CYT levels were significantly associated with tumor immune response factors, such as CD19, CD86, LTA, HLA-B, LAG3 and A2AR, in primary tumors but not in metastatic sites (Fig 3B, lower row). The gene discussed is ADORA2A; the disease is neoplasm.